Related Experiment Video
Updated: May 14, 2026
08:46
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)
Published on: March 7, 2017
Brainstem gangliogliomas: a retrospective series
Si Zhang1, Xiang Wang, Xuesong Liu
1Department of Neurosurgery, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.
Journal of Neurosurgery
|February 5, 2013
Summary
Brainstem gangliogliomas, rare tumors, show favorable prognoses with maximal safe resection and observation. Adjuvant therapies are not typically needed for these WHO Grade I or II tumors.
Area of Science:
- Neuro-oncology
- Pediatric Neurosurgery
- Neuropathology
Background:
- Brainstem gangliogliomas are rare tumors requiring specific diagnostic and management strategies.
- Understanding their preoperative characteristics and clinical outcomes is crucial for effective treatment.
Observation:
- A retrospective analysis of 7 brainstem ganglioglioma cases treated between 2006-2012.
- Patients presented with cranial nerve deficits and cerebellar signs.
- Tumors were pathologically diagnosed as WHO Grade I or II ganglioglioma.
Findings:
- Maximal safe resection was performed in all cases, with subtotal resection in 2 and partial resection in 5.
- No adjuvant radiotherapy or chemotherapy was administered.
- Follow-up showed stable or resolved symptoms with no tumor progression or recurrence.
Implications:
- Brainstem gangliogliomas have a favorable prognosis, supporting maximal safe surgical resection.
- Close observation without adjuvant therapy appears to be the optimal management strategy.
- This approach can lead to long-term stability and symptom resolution.
